Allcore SpA
MIL:CORE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Allcore SpA
MIL:CORE
|
IT |
|
Clariane SE
PAR:CLARI
|
FR |
|
Adaptimmune Therapeutics PLC
NASDAQ:ADAP
|
UK |
|
J
|
Jetema Co Ltd
KOSDAQ:216080
|
KR |
|
Talphera Inc
NASDAQ:TLPH
|
US |
|
Cortina Holdings Ltd
SGX:C41
|
SG |
|
Redcare Pharmacy NV
F:RDC
|
NL |
Wall Street
Price Targets
CORE Price Targets Summary
Allcore SpA
According to Wall Street analysts, the average 1-year price target for CORE is 2.72 EUR with a low forecast of 2.61 EUR and a high forecast of 2.89 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CORE's stock price target?
Price Target
2.72
EUR
According to Wall Street analysts, the average 1-year price target for CORE is 2.72 EUR with a low forecast of 2.61 EUR and a high forecast of 2.89 EUR.
What is Allcore SpA's Revenue forecast?
Projected CAGR
12%
For the last 4 years the compound annual growth rate for Allcore SpA's revenue is 23%. The projected CAGR for the next 4 years is 12%.
What is Allcore SpA's Operating Income forecast?
Projected CAGR
26%
For the last 4 years the compound annual growth rate for Allcore SpA's operating income is 25%. The projected CAGR for the next 4 years is 26%.
What is Allcore SpA's Net Income forecast?
Projected CAGR
51%
For the last 4 years the compound annual growth rate for Allcore SpA's net income is 6%. The projected CAGR for the next 3 years is 51%.
